BOUCHAL, Pavel, Monika MUDROCHOVÁ, Zbyněk BORTLÍČEK, Theodoros ROUMELIOTIS, Eva BUDINSKÁ, Dominika VÁŇOVÁ, Lenka HERNYCHOVÁ, Iva STRUHÁROVÁ, Roman HRSTKA, Petr MÜLLER, Alexander SCHERL, Spiros D. GARBIS, Rudolf NENUTIL and Bořivoj VOJTĚŠEK. Biomarker discovery in low-grade breast cancer: An integrated, proteomics-based approach. In Abstract book of "3rd joint meeting on the role of p53, MDM2, AGR2/3 and ubiquitin/chaperone system in tumour biology". 2010. ISBN 978-80-86793-16-0.
Other formats:   BibTeX LaTeX RIS
Basic information
Original name Biomarker discovery in low-grade breast cancer: An integrated, proteomics-based approach
Name in Czech Vyhledávání biomarkerů low-grade karcinomu prsu: Integrovaný přístup na bázi proteomiky
Authors BOUCHAL, Pavel, Monika MUDROCHOVÁ, Zbyněk BORTLÍČEK, Theodoros ROUMELIOTIS, Eva BUDINSKÁ, Dominika VÁŇOVÁ, Lenka HERNYCHOVÁ, Iva STRUHÁROVÁ, Roman HRSTKA, Petr MÜLLER, Alexander SCHERL, Spiros D. GARBIS, Rudolf NENUTIL and Bořivoj VOJTĚŠEK.
Edition Abstract book of "3rd joint meeting on the role of p53, MDM2, AGR2/3 and ubiquitin/chaperone system in tumour biology" 2010.
Other information
Original language English
Type of outcome Conference abstract
Field of Study 30200 3.2 Clinical medicine
Country of publisher Czech Republic
Confidentiality degree is not subject to a state or trade secret
Organization unit Faculty of Science
ISBN 978-80-86793-16-0
Keywords (in Czech) rakovina prsu; uzlinové metastáze proteomika
Keywords in English breast cancer; metastasis; proteomics
Tags International impact
Changed by Changed by: doc. Mgr. Pavel Bouchal, Ph.D., učo 8757. Changed: 4/5/2011 12:14.
Abstract
Breast cancer is the most common women cancer in the world. Traditional prognostic markers are, however, not sufficient for precise risk-group discrimination. Our effort has been focused on biomarker discovery in the set of 96 breast cancer primary tumors divided into several groups according to grade, lymph node and hormonal receptor status. Three proteomics approaches were involved in complex protein analysis of tissue lysates: SELDI-TOF MS, iTRAQ-2DLC-MS/MS and 2-D SDS-PAGE. Generally, our results indicate the following differences between the two studied groups: Differential expression of (i) cytoskeletal proteins, (ii) AGR family members and (iii) proteins involved in heme biosynthesis. These findings provide a solid data for further verification, functional studies and validation geared toward the establishment of novel biomarkers of metastatic processes in breast cancer.
Links
GAP304/10/0868, research and development projectName: Studium molekulárních mechanismů časného metastazování do lymfatických uzlin u karcinomu prsu nízkého stupně malignity pomocí proteomických technik
Investor: Czech Science Foundation
GA301/08/1468, research and development projectName: Úloha E3-ligáz a inhibitorů heat shock proteinů při studiu molekulárních a buněčných konsekvencí regulace proteinu p53.
MZ0MOU2005, plan (intention)Name: Funkční diagnostika zhoubných nádorů
PrintDisplayed: 25/5/2024 05:44